Last reviewed · How we verify
Inactivated HAV Vaccine, TZ84 Strain — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Inactivated HAV Vaccine, TZ84 Strain (Inactivated HAV Vaccine, TZ84 Strain) — Institute of Medical Biology, Chinese Academy of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Inactivated HAV Vaccine, TZ84 Strain TARGET | Inactivated HAV Vaccine, TZ84 Strain | Institute of Medical Biology, Chinese Academy of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Inactivated HAV Vaccine, TZ84 Strain CI watch — RSS
- Inactivated HAV Vaccine, TZ84 Strain CI watch — Atom
- Inactivated HAV Vaccine, TZ84 Strain CI watch — JSON
- Inactivated HAV Vaccine, TZ84 Strain alone — RSS
Cite this brief
Drug Landscape (2026). Inactivated HAV Vaccine, TZ84 Strain — Competitive Intelligence Brief. https://druglandscape.com/ci/inactivated-hav-vaccine-tz84-strain. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab